Effects of metoprolol succinate extended release vs. amlodipine besylate on the blood pressure, heart rate, and the rate-pressure product in patients with hypertension

Journal of the American Society of Hypertension

Volumn 2, Issue 5, 2008, Pages 378-384

  White, William B ^a   Krishnan, Subramanian ^a   Giacco, Sharon ^a   Mallareddy, Madhavi ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Ambulatory blood pressure measurement; amlodipine; antihypertensive therapy; metoprolol

Indexed keywords

AMLODIPINE BESYLATE; METOPROLOL SUCCINATE; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HEART RATE; HEMODYNAMIC MONITORING; HOT FLUSH; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; MIDDLE AGED; MORNING DOSAGE; PRIORITY JOURNAL; TABLET FORMULATION; UPPER RESPIRATORY TRACT INFECTION;

EID: 51449110987     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2008.03.002     Document Type: Article

References (24)

1. White W.B., and Morganroth J. Usefulness of ambulatory blood pressure monitoring in assessing antihypertensive therapy. Am J Cardiol 63 (1989) 94-98
2. Mansoor G.A., and White W.B. Ambulatory blood pressure and cardiovascular risk. J Vasc Med Biol 5 (1994) 61-68
3. White W.B. Methods of blood pressure determination to assess antihypertensive therapy. Are casual measurements enough?. Clin Pharmacol Ther 45 (1989) 581-586
4. Muller J.E., Tofler G.H., and Stone P.H. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 79 (1989) 733-743
5. Marler J.R., Price T.R., Clark G.L., Muller J.E., Robertson T., Mohr J.P., et al. Morning increase in the onset of ischemic stroke. Stroke 20 (1989) 473-476
6. White W.B. Circadian variation of blood pressure: clinical relevance and implications for cardiovascular chronotherapeutics. Blood Press Monit 2 (1997) 47-52
7. Anwar Y.A., and White W.B. Chronotherapeutics for cardiovascular disease. Drugs 55 (1998) 631-643
8. White W.B., Anders R.J., MacIntyre J.M., Black H.R., and Sica D.A. Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Am J Cardiol 76 (1995) 375-380
9. White W.B., Black H.R., Weber M.A., Elliott W.J., Bryzinski B., and Fakouhi T.D. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart-rate blood pressure product. Am J Cardiol 81 (1998) 424-431
10. White W.B. Advances in ambulatory blood pressure monitoring to assess the effects of antihypertensive therapy. In: White W.B. (Ed). Blood pressure monitoring in cardiovascular medicine and therapeutics. 2nd edition (2007), Humana Press, Totowa, New Jersey 437-462
11. Palatini P., and Julius S. HR and cardiovascular risk. J Hypertens 15 (1997) 3-17
12. Gillman M.W., Kannel W.B., Belanger A., and D'Agostino R.B. Influence of heart rate on mortality among persons with hypertension; The Framingham Study. Am Heart J 125 (1993) 1148-1154
13. Levy R.L., White P.D., Stroud W.D., and Hilman C.C. Transient tachycardia: prognostic significance alone and in association with transient hypertension. JAMA 129 (1945) 585-588
14. Kawano Y., Tochikubo O., Minamisawa K., Miyajima E., and Ishii M. Circadian variation of hemodynamics in patients with essential hypertension: comparison between early morning and evening. J Hypertens 12 (1994) 1405-1412
15. Cheitlin M.D., Sokolow M., and McIlroy M.B. Anatomy and physiology of the circulatory system. Clinical cardiology. 6th edition (1993), Appleton & Lange, Norwalk, Connecticut 1-38
16. Deedwania P.C., and Nelson J.R. Pathophysiology of silent myocardial ischemia during daily life: hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation 82 (1990) 1296-1304
17. Olakunle O.A., Reichek N., Bergmann S.R., and Chou R.L. Correlates of myocardial oxygen demand measured by positron emission tomography in the hypertrophied left ventricle. Am J Hypertens 16 (2003) 240-243
18. Goodwin J., Bilious M., Winship S., Finn P., and Jones S.C. Validation of the Oscar 2 oscillometric 24-hour ambulatory blood pressure monitor according to the British Hypertension Society protocol. Blood Press Monit 12 (2007) 113-117
19. White W.B., Schulman P., Karimeddini M.K., and Smith V.E. Regression of left ventricular mass is accompanied by rapid left ventricular filling following antihypertensive therapy with metoprolol. Am Heart J 117 (1989) 145-150
20. Soucek M., Rihacek I., and Frana P. A comparison of the trough-to-peak ratio of cardioselective beta-blockers in patients with newly diagnosed hypertension. Blood Press Monit 11 (2006) 337-342
21. White W.B., Sica D.A., Calhoun D., Mansoor G.A., and Anders R.J. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising. Am Heart J 144 (2002) 657-665
22. Lund-Johansen P. Blood pressure and heart rate responses during physical exercise in hypertension-modifications by drug treatment. Eur Heart J 20 (1999) B10-B17
23. Beitelshees A.L., Zineh I., Yarnadi H.N., Pauly D.F., and Johnson J.A. Discordant beta-blocker effects on clinic, ambulatory, and exercise hemodynamics in patients with hypertension. Pharmacotherapy 26 (2006) 1247-1254
24. Frishman W.H., Hainer J.W., and Sugg J. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release. Am J Hypertens 19 (2006) 388-395